Search research articles
Contact Us
Filters
Showing results (51-60 of 54) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 54 results.
Journal of Occupational and Environmental Medicine
|
June 20, 2017
Cardio-Respiratory Effects of Air Pollution in a Panel Study of Outdoor Physical Activity and Health in Rural Older Adults
David M Stieb, Robin Shutt, Lisa Kauri, et al.
Annals of Neurology
|
October 5, 2018
Outcome of cell suspension allografts in a patient with Huntington's disease
Alexander Maxan, Sarah Mason, Martine Saint-Pierre, et al.
International Journal of Environmental Health Research
|
December 13, 2019
Associations between air pollution and cardio-respiratory physiological measures in older adults exercising outdoors
David Stieb, Robin H Shutt, Lisa M Kauri, et al.
Lancet (London, England)
|
January 14, 2014
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
Stéphane Palfi, Jean Marc Gurruchaga, G Scott Ralph, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 54) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 54 results.
Journal of Occupational and Environmental Medicine
|
June 20, 2017
Cardio-Respiratory Effects of Air Pollution in a Panel Study of Outdoor Physical Activity and Health in Rural Older Adults
David M Stieb, Robin Shutt, Lisa Kauri, et al.
Annals of Neurology
|
October 5, 2018
Outcome of cell suspension allografts in a patient with Huntington's disease
Alexander Maxan, Sarah Mason, Martine Saint-Pierre, et al.
International Journal of Environmental Health Research
|
December 13, 2019
Associations between air pollution and cardio-respiratory physiological measures in older adults exercising outdoors
David Stieb, Robin H Shutt, Lisa M Kauri, et al.
Lancet (London, England)
|
January 14, 2014
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
Stéphane Palfi, Jean Marc Gurruchaga, G Scott Ralph, et al.
Page
of 6